No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
RNAZ Transcode Therapeutics
- 1.189
- -0.011-0.90%
Trading Jun 17 09:59 ET
7.87MMarket Cap0.00P/E (TTM)
1.205High1.160Low62.31KVolume1.160Open1.200Pre Close72.80KTurnover0.99%Turnover Ratio0.00P/E (Static)6.62MShares128.00052wk High1.72P/B7.46MFloat Cap0.42052wk Low--Dividend TTM6.28MShs Float5600.000Historical High--Div YieldTTM3.73%Amplitude0.420Historical Low1.168Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | TransCode Therapeutics Shares Are Trading Higher After the Company Announced That It Regained Compliance With the Nasdaq's Continued Listing Requirements
Express News | Nasdaq Determines That Transcode Therapeutics Has Regained Compliance With Continued Listing Requirements
Nasdaq Determines That TransCode Therapeutics Has Regained Compliance With Continued Listing Requirements
BOSTON, June 10, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ:RNAZ), (the "Company"), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that
12 Health Care Stocks Moving In Friday's After-Market Session
GainersAnitra (AMEX:AZTR) stock rose 17.0% to $0.17 during Friday's after-market session. The company's market cap stands at $5.0 million. Scinai Immunotherapeutics (NASDAQ:SCNI) stock increased by 12
Express News | TransCode Therapeutics Regains Compliance With Minimum Bid Price Requirement Per Nasdaq Listing Rule 5550(A)(2)
Express News | Transcode Therapeutics : Has Regained Compliance With Minimum Bid Price Requirement Set Forth in Nasdaq Listing Rule 5550(a)(2)
Comments
Buy it ya all
$Transcode Therapeutics(RNAZ.US$ is it a good time to buy or should I wait? I think it's gonna go up tomorrow.
1
$Transcode Therapeutics(RNAZ.US$
TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138
TransCode Therapeutics (NASDAQ: RNAZ) announced positive preliminary data from its Phase 0 clinical trial for TTX-MC138, their lead RNA-based therapeutic candidate. The trial showed significant inhibition of the molecular target miRNA-10b, with a 66% reduction in the patient's blood 24 hours post-administration. This inhibition is...
TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138
TransCode Therapeutics (NASDAQ: RNAZ) announced positive preliminary data from its Phase 0 clinical trial for TTX-MC138, their lead RNA-based therapeutic candidate. The trial showed significant inhibition of the molecular target miRNA-10b, with a 66% reduction in the patient's blood 24 hours post-administration. This inhibition is...
1
1
$Transcode Therapeutics(RNAZ.US$ what do you make of this pre-market activity ?
I am not a financial advisor
$Borealis Foods Inc. (BRLS)$: +98.75%.
$Snap Inc. (SNAP)$: Notable increase following positive news and potential regulatory changes.
$Mullen Automotive Inc. (MULN)$: Volatile with low float, ideal for day traders.
$TransCode Therapeutics, Inc. (RNAZ)$: +55.65% due to advances in biotechnology.
$Akso Health Group (AHG)$: +67.14%, with growth in the health sector.
$Accelerate Diagnostics, Inc. (AXDX)$: +56.46%, momentum in medical diagnostics.
$Bakkt Holdings, Inc. (B...
$Borealis Foods Inc. (BRLS)$: +98.75%.
$Snap Inc. (SNAP)$: Notable increase following positive news and potential regulatory changes.
$Mullen Automotive Inc. (MULN)$: Volatile with low float, ideal for day traders.
$TransCode Therapeutics, Inc. (RNAZ)$: +55.65% due to advances in biotechnology.
$Akso Health Group (AHG)$: +67.14%, with growth in the health sector.
$Accelerate Diagnostics, Inc. (AXDX)$: +56.46%, momentum in medical diagnostics.
$Bakkt Holdings, Inc. (B...
2
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg